Prasugrel

The antithrombotic therapy in patients with atherosclerotic vascular disease is subject of several new therapeutic approaches. Simultaneous treatment with aspirin and a thienopyridin (clopidogrel) represents the standard of care for patients with acute coronary syndrome and following coronary stenti...

Full description

Saved in:
Bibliographic Details
Published inHämostaseologie Vol. 32; no. 3; p. 186
Main Author Darius, H
Format Journal Article
LanguageGerman
Published Germany 2012
Subjects
Evidence-Based Medicine
Fibrinolytic Agents - administration & dosage
Fibrinolytic Agents - adverse effects
Humans
Piperazines - administration & dosage
Piperazines - adverse effects
Prasugrel Hydrochloride
Purinergic P2Y Receptor Antagonists - administration & dosage
Purinergic P2Y Receptor Antagonists - adverse effects
Thiophenes - administration & dosage
Thiophenes - adverse effects
Thrombosis - drug therapy
Thrombosis - prevention & control
Treatment Outcome
Online AccessGet more information
ISSN0720-9355
DOI10.5482/HAMO-12-05-0007

Cover